Bivalent influenza vaccine (6:2 reassortant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bivalent influenza vaccine (6:2 reassortant), covering 2007-05-09 to 2007-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults [Phase 3]